Werewolf Therapeutics, Inc. · NASDAQ:HOWL

Luke Evnin sold 100,581 Werewolf Therapeutics, Inc. shares (Form 4)

Traded May 5 to May 7, 2026 · Filed May 7, 2026

From May 5 to May 7, 2026, Luke Evnin (Director) sold 100,581 Werewolf Therapeutics, Inc. shares at an average US$0.64 for US$64,217 under a trading plan, leaving 1,578,749 shares. Filed May 7, 2026 (Form 4).

Sold
100,581 shares
Price
US$0.64 average (US$0.63 to US$0.69)
Value
US$64,217
Holding after
1,578,749 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 5, 2026Common StockSale6,860US$0.691,672,470Indirect
May 6, 2026Common StockSale14,635US$0.661,657,835Indirect
May 7, 2026Common StockSale79,086US$0.631,578,749Indirect

Source

View original at SEC

Related